Founded in Cambridge, Massachusetts, Scholar Rock Holding Corporation is a biopharmaceutical company dedicated to discovering and developing innovative treatments for neuromuscular disorders, cancer, fibrosis, and anemia. The company's core mission is to unlock fundamentally different therapeutic approaches through bold science and a unique drug discovery platform. Scholar Rock's products and services focus on advancing the standard of care by targeting protein growth factors that are fundamental to disease progression.

Notable affiliated people include leading scientists and industry experts who contribute to Scholar Rock's pioneering research. The company has attracted significant investment from top-tier venture capital firms, fueling its growth and innovation. Key achievements include the development of a robust pipeline of potential therapies that have shown promise in preclinical and clinical trials. Scholar Rock's impact lies in its potential to transform treatment paradigms and improve outcomes for patients with serious diseases.